Delivery Order SPE2DB22D3016-SPE2DB25FABS0

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,283.49 firm fixed-price delivery order is for the supply of 4,566,178,214 units of doxycycline hyclate 100 mg capsules. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,619,033 units of Doxycycline Hyclate 100 mg capsules. The fixed-price delivery order, valued at $1,350.96, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,511,468 units of Doxycycline 100mg in 1,000 count containers. The $3,365.38 firm fixed-price Delivery Order contract has a completion date of December 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,164.84 and is a delivery order for 4,567,649,603 units of Doxycycline Hyclate 100 mg tablets. The contract has an ultimate completion date of March 24, 2025 and is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,420.51 firm fixed-price delivery order is for the supply of 4,564,544 units of doxycycline monohydrate 100 mg capsules. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $3,442.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 capsules of Doxycycline Hyclate 100 mg, a generic antibiotic medication. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,173,863 units of doxycycline monohydrate 100 mg capsules. The $4,487.10 firm fixed-price delivery order has a performance period through May 8, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,111.99 firm fixed-price delivery order is for the supply of 4,567,571,531 units of Doxycycline Mono 100 mg capsules in 50-count packages. The award has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of 4,565,792,375 units of Doxycycline Hyclate 100 mg tablets in 1,000 count bottles. The contract has a firm fixed price of $3,699.36 and a completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, was awarded this delivery order contract to provide essential pharmaceutical products to support military treatment...
This federal contract award, valued at $2,214.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D1113|SPE2DX25FBJMF) for the supply of 4,568,073,068 units of Doxycycline Hyclate 100 mg tablets. The contract is a firm fixed-price arrangement with an ultimate completion date of April 30, 2025. This award is not designated as a set-aside contract,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FABS0
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,250 units of Doxycycline Hyclate 100mg capsules. The $3,260.04 firm fixed-price contract has an ultimate completion date of October 29, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/2/25, 12:07 AM